General Information of Drug (ID: DM53Z4I)

Drug Name
US9040714, 7 Drug Info
Synonyms SCHEMBL14924888; CHEMBL3639668; BDBM160340; US9040714, 7
Cross-matching ID
PubChem CID
89548086
TTD Drug ID
DM53Z4I

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ORIN1001 DM27RXS Metastatic breast cancer 2C6Y Phase 1/2 [2]
T8361 DM86BDS N. A. N. A. Patented [3]
US8614253, 29-1 DMJKFVU N. A. N. A. Patented [4]
US8614253, 32-5 DMSQODK N. A. N. A. Patented [3]
US8614253, 29-19 DMVI83P N. A. N. A. Patented [5]
879325-11-8 DMP04Z6 N. A. N. A. Patented [1]
AC1LE05K DMPOR3G N. A. N. A. Patented [6]
US8614253, 32-4 DMRSP2M N. A. N. A. Patented [5]
BB 0223767 DM2DT6L N. A. N. A. Patented [3]
US9241942, 32-12 DM8GW54 N. A. N. A. Patented [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endoplasmic reticulum to nucleus signaling 1 (ERN1) TTOJ9QL ERN1_HUMAN Inhibitor [1]

References

1 IRE-1 inhibitors. US9040714.
2 Clinical pipeline report, company report or official report of Orinove.
3 IRE-1 inhibitors. US8614253.
4 IRE-1 inhibitors. US9241942.
5 IRE-1 inhibitors. US9493435.
6 IRE-1 inhibitors. US9693992.